Skip to main content


Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Fig. 5 | Breast Cancer Research

Fig. 5

From: Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer

Fig. 5

[177Lu]-PSMA-617 decreases viability of TNBC-conditioned HUVEC cells and impairs their potential for tube formation. a Bright field microscopy imaging of tube formation efficiency of HUVEC cells incubated without or with [177Lu]-PSMA-617 in different medium. b HUVEC cell vitality after incubation in different media without or with [177Lu]-PSMA-617. Data are representative of two independent experiments with triplicates (n = 6). Bars, ± SEM

Back to article page